IL6R and central nervous system cancer: Functionally, OSMR - a leukocyte interleukin-6 receptor- activates JAK-STAT3 signaling upon binding oncostatin M (OSM), thereby driving glioma proliferation, invasion, and apoptosis resistance [32].